Cagrilintide

Cagrilintide (CAS 1415456-99-3) is offered as a laboratory research reference material intended strictly for in-vitro and laboratory research use. The compound is a 37-residue synthetic peptide analog belonging to the amylin/calcitonin family of reference peptides, supplied as a white to off-white lyophilized powder suitable for analytical characterization, chromatographic method development, mass spectrometry reference work, and comparative structure-activity investigations conducted in a controlled laboratory setting.

The primary structure of Cagrilintide is KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY (Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr), placing the two cysteine residues at positions 2 and 7 to accommodate an intramolecular disulfide bridge that constrains the N-terminal loop, a structural feature shared with the broader amylin analog reference class. The sequence is rich in serine, asparagine, and threonine residues, contributing to its polarity profile and to characteristic behavior during reversed-phase HPLC and hydrophilic-interaction analyses.

Cagrilintide is defined by the molecular formula C171H266N42O55S2 and a molecular weight of approximately 3789 g/mol, with the two sulfur atoms corresponding to the paired cysteine residues. These parameters make it a useful monoisotopic and average-mass reference point for high-resolution LC-MS, MALDI-TOF, and peptide mapping workflows, and the defined residue composition supports orthogonal identity confirmation by amino acid analysis or Edman-based sequencing where required.

Material is produced by chemical synthesis (solid-phase methodology consistent with modern Fmoc peptide chemistry) and released at a purity of not less than 98% by HPLC, with identity and purity documented on the lot-specific Certificate of Analysis available on request. The lyophilized physical form supports extended cold-chain stability for reference-standard applications and allows the analyst to reconstitute in a solvent system appropriate to the intended in-vitro assay, calibration curve, or comparator study.

Published scientific literature has examined Cagrilintide in preclinical research contexts, and this listing is provided solely to support qualified investigators in identifying and characterizing the compound. PEPTIDE.Power makes no therapeutic, diagnostic, or efficacy claims regarding Cagrilintide and provides no administration or dosing guidance. This material is not a drug, supplement, cosmetic, or food; it is not for human or veterinary use, injection, or ingestion, and is intended exclusively for laboratory reference and in-vitro research by trained personnel.

Supplied as a lyophilized (freeze-dried) powder in a sealed vial. A research reference material - not a finished product and not a delivery device. Net contents per unit are shown in the product options.

Store the sealed lyophilized powder at -20 C, protected from light and moisture. After reconstitution for laboratory use, keep cold and use promptly. Handle per standard laboratory practice; a Safety Data Sheet (SDS) is available on request.

This material is sold to qualified laboratory and research buyers for lawful research use only. It is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. By purchasing, you confirm you are 21 or older and will use this material only for lawful laboratory research.